Investment Trusts

RTW Biotech Opportunities Ltd

RTW:LSE

RTW Biotech Opportunities Ltd

  • Price (USD)1.37
  • Today's Change0.02 / 1.48%
  • Shares traded28.82k
  • 1 Year change8.30%
  • Beta0.6188
Data delayed at least 20 minutes, as of May 09 2024 16:35 BST.
More ▼
Total returns on $1000
1Y
Fund/benchmarkChange
PriceRTW Biotech Opportunities Ltd (Ordinary Share)+6.30%
NAVRTW Biotech Opportunities Ltd (Ordinary Share)+15.38%
Morningstar's Benchmark(Russell 2000 Biotech Growth) 50.000% + ( Nasdaq Biotechnology Index) 50.000%--

Key statistics

On Thursday, RTW Biotech Opportunities Ltd (RTW:LSE) closed at 1.37, -4.20% below its 52-week high of 1.43, set on Jan 31, 2024.
52-week range
Today
1.05Nov 02 20231.43Jan 31 2024
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Shares outstanding384.69m
Market cap519.33m USD
Total assets750.14m USD
Total expense ratio1.97%
High1.37
Low1.34
Previous close1.35
Average volume544.66k
YTD Change-2.32%
Beta0.6188
Diluted NAV (est)1.95
Diluted NAV (last pub)1.95
Premium/Discount-30.77%
Net Gearing0.00%
Data delayed at least 20 minutes, as of May 09 2024 16:35 BST.
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.